Compare $IART vs $PRCT | Chartloom

Compare

$IART vs $PRCT

Integra Lifesciences Holdings Corp · Procept Biorobotics Corp

IART

Integra Lifesciences Holdings Corp

PRCT

Procept Biorobotics Corp

Compare $IART vs $PRCT

Comparing Integra Lifesciences Holdings Corp and Procept Biorobotics Corp

IARTIntegra Lifesciences Holdings Corp

PRCTProcept Biorobotics Corp

IARTIntegra Lifesciences Holdings Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

4.99x

Forward P/S (NTM)

0.60x

Rev growth (TTM)

0.8%

YTD performance

11.9%

52W performance

-9.3%

FCF yield

-1.4%

PRCTProcept Biorobotics Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.35x

Rev growth (TTM)

22.7%

YTD performance

-40.2%

52W performance

-47.1%

FCF yield

-8.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IART

PRCT

Detailed metrics comparison

IART

Integra Lifesciences Holdings Corp

PRCT

Procept Biorobotics Corp

Market Cap

IART$1.05B

PRCT$1.05B

Enterprise Value

IART$1.05B

PRCT$871M

Price

IART$13.44

PRCT$18.40

P/E Ratio

IARTN/A

PRCTN/A

P/S Ratio

IART0.63x

PRCT3.10x

EV/Sales

IART0.63x

PRCT2.58x

EV/EBITDA

IART3.92x

PRCT0.00x

P/B Ratio

IART0.95x

PRCT2.89x

P/FCF Ratio

IARTN/A

PRCTN/A

EV/FCF

IART-73.87x

PRCT-10.26x

PEG Ratio

IARTN/A

PRCTN/A

Forward P/E (NTM)

IART4.99x

PRCTN/A

Forward P/S (NTM)

IART0.60x

PRCT2.35x

Revenue (TTM)

IART$1.66B

PRCT$337M

Revenue Growth (YoY)

IART0.8%

PRCT22.7%

Forward Rev Growth

IART3.2%

PRCT20.6%

Gross Margin (TTM)

IART43.1%

PRCT64.2%

Operating Margin (TTM)

IART4.0%

PRCT0.0%

EBITDA Margin (TTM)

IART16.1%

PRCT-31.8%

Net Margin (TTM)

IART-0.1%

PRCT-32.5%

FCF Margin (TTM)

IART-0.9%

PRCT-25.2%

Net Income (TTM)

IART$-2M

PRCT$-110M

FCF (TTM)

IART$-14M

PRCT$-85M

EPS (TTM)

IART$0.00

PRCT-$1.92

ROE (TTM)

IART-70.0%

PRCT-3062.0%

ROA (TTM)

IART-20.0%

PRCT-2211.0%

ROIC (TTM)

IART-25.0%

PRCT-2676.0%

Cash

IART$0

PRCT$228M

Debt

IART$0

PRCT$52M

Net Cash/Debt

IART$0

PRCT$176M

Current Ratio (TTM)

IART3.60x

PRCT6.55x

Quick Ratio (TTM)

IART1.80x

PRCT5.23x

Debt/Equity (TTM)

IART1.79x

PRCT0.15x

Debt/Assets (TTM)

IART0.0%

PRCT0.0%

Interest Coverage (TTM)

IARTN/A

PRCTN/A

Net Debt/EBITDA (TTM)

IART0.00x

PRCT0.00x

Beta

IART1.27

PRCT0.88

52W Performance

IART-9.3%

PRCT-47.1%

YTD Performance

IART11.9%

PRCT-40.2%

% from 52W High

IART-34.4%

PRCT-51.7%

% from 52W Low

IART54.5%

PRCT10.4%

Asset Turnover (TTM)

IART0.46x

PRCT0.68x

FCF Yield (TTM)

IART-1.4%

PRCT-8.1%

Earnings Yield (TTM)

IART-0.2%

PRCT-10.5%

Dividend Yield (TTM)

IARTN/A

PRCTN/A

Rule of 40

IART-0.0

PRCT-2.5

EV/GP/RG

IART0.26

PRCT0.12

Ticker research

View IART research View PRCT research

Metric	IART Integra Lifesciences Holdings Corp	PRCT Procept Biorobotics Corp
Market & Valuation
Market Cap	$1.05B	$1.05B
Enterprise Value	$1.05B	$871M
Price	$13.44	$18.40
P/E Ratio	N/A	N/A
P/S Ratio	0.63x	3.10x
EV/Sales	0.63x	2.58x
EV/EBITDA	3.92x	0.00x
P/B Ratio	0.95x	2.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-73.87x	-10.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	4.99x	N/A
Forward P/S (NTM)	0.60x	2.35x
Revenue & Growth
Revenue (TTM)	$1.66B	$337M
Revenue Growth (YoY)	0.8%	22.7%
Forward Rev Growth	3.2%	20.6%
Profitability
Gross Margin (TTM)	43.1%	64.2%
Operating Margin (TTM)	4.0%	0.0%
EBITDA Margin (TTM)	16.1%	-31.8%
Net Margin (TTM)	-0.1%	-32.5%
FCF Margin (TTM)	-0.9%	-25.2%
Net Income (TTM)	$-2M	$-110M
FCF (TTM)	$-14M	$-85M
EPS (TTM)	$0.00	-$1.92
ROE (TTM)	-70.0%	-3062.0%
ROA (TTM)	-20.0%	-2211.0%
ROIC (TTM)	-25.0%	-2676.0%
Financial Health
Cash	$0	$228M
Debt	$0	$52M
Net Cash/Debt	$0	$176M
Current Ratio (TTM)	3.60x	6.55x
Quick Ratio (TTM)	1.80x	5.23x
Debt/Equity (TTM)	1.79x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.27	0.88
52W Performance	-9.3%	-47.1%
YTD Performance	11.9%	-40.2%
% from 52W High	-34.4%	-51.7%
% from 52W Low	54.5%	10.4%
Efficiency & Yields
Asset Turnover (TTM)	0.46x	0.68x
FCF Yield (TTM)	-1.4%	-8.1%
Earnings Yield (TTM)	-0.2%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.0	-2.5
EV/GP/RG	0.26	0.12
Ticker research	View IART research	View PRCT research

Valuation

P/S Ratio

IART

0.63x

PRCT

3.10x

EV/FCF

IART

-73.87x

PRCT

-10.26x

Growth & revenue

Revenue Growth TTM

PRCT

22.7%

IART

0.8%

Forward Revenue Growth

PRCT

20.6%

IART

3.2%

Profitability & performance

Gross Margin

PRCT

64.2%

IART

43.1%

ROE

IART

-70.0%

PRCT

-3062.0%

FCF Yield %

IART

-1.4%

PRCT

-8.1%

52-Week Performance

IART

-9.3%

PRCT

-47.1%

Detailed metrics comparison

IART

Integra Lifesciences Holdings Corp

PRCT

Procept Biorobotics Corp

Market Cap

IART$1.05B

PRCT$1.05B

Enterprise Value

IART$1.05B

PRCT$871M

Price

IART$13.44

PRCT$18.40

P/E Ratio

IARTN/A

PRCTN/A

P/S Ratio

IART0.63x

PRCT3.10x

EV/Sales

IART0.63x

PRCT2.58x

EV/EBITDA

IART3.92x

PRCT0.00x

P/B Ratio

IART0.95x

PRCT2.89x

P/FCF Ratio

IARTN/A

PRCTN/A

EV/FCF

IART-73.87x

PRCT-10.26x

PEG Ratio

IARTN/A

PRCTN/A

Forward P/E (NTM)

IART4.99x

PRCTN/A

Forward P/S (NTM)

IART0.60x

PRCT2.35x

Revenue (TTM)

IART$1.66B

PRCT$337M

Revenue Growth (YoY)

IART0.8%

PRCT22.7%

Forward Rev Growth

IART3.2%

PRCT20.6%

Gross Margin (TTM)

IART43.1%

PRCT64.2%

Operating Margin (TTM)

IART4.0%

PRCT0.0%

EBITDA Margin (TTM)

IART16.1%

PRCT-31.8%

Net Margin (TTM)

IART-0.1%

PRCT-32.5%

FCF Margin (TTM)

IART-0.9%

PRCT-25.2%

Net Income (TTM)

IART$-2M

PRCT$-110M

FCF (TTM)

IART$-14M

PRCT$-85M

EPS (TTM)

IART$0.00

PRCT-$1.92

ROE (TTM)

IART-70.0%

PRCT-3062.0%

ROA (TTM)

IART-20.0%

PRCT-2211.0%

ROIC (TTM)

IART-25.0%

PRCT-2676.0%

Cash

IART$0

PRCT$228M

Debt

IART$0

PRCT$52M

Net Cash/Debt

IART$0

PRCT$176M

Current Ratio (TTM)

IART3.60x

PRCT6.55x

Quick Ratio (TTM)

IART1.80x

PRCT5.23x

Debt/Equity (TTM)

IART1.79x

PRCT0.15x

Debt/Assets (TTM)

IART0.0%

PRCT0.0%

Interest Coverage (TTM)

IARTN/A

PRCTN/A

Net Debt/EBITDA (TTM)

IART0.00x

PRCT0.00x

Beta

IART1.27

PRCT0.88

52W Performance

IART-9.3%

PRCT-47.1%

YTD Performance

IART11.9%

PRCT-40.2%

% from 52W High

IART-34.4%

PRCT-51.7%

% from 52W Low

IART54.5%

PRCT10.4%

Asset Turnover (TTM)

IART0.46x

PRCT0.68x

FCF Yield (TTM)

IART-1.4%

PRCT-8.1%

Earnings Yield (TTM)

IART-0.2%

PRCT-10.5%

Dividend Yield (TTM)

IARTN/A

PRCTN/A

Rule of 40

IART-0.0

PRCT-2.5

EV/GP/RG

IART0.26

PRCT0.12

Ticker research

View IART research View PRCT research

Metric	IART Integra Lifesciences Holdings Corp	PRCT Procept Biorobotics Corp
Market & Valuation
Market Cap	$1.05B	$1.05B
Enterprise Value	$1.05B	$871M
Price	$13.44	$18.40
P/E Ratio	N/A	N/A
P/S Ratio	0.63x	3.10x
EV/Sales	0.63x	2.58x
EV/EBITDA	3.92x	0.00x
P/B Ratio	0.95x	2.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-73.87x	-10.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	4.99x	N/A
Forward P/S (NTM)	0.60x	2.35x
Revenue & Growth
Revenue (TTM)	$1.66B	$337M
Revenue Growth (YoY)	0.8%	22.7%
Forward Rev Growth	3.2%	20.6%
Profitability
Gross Margin (TTM)	43.1%	64.2%
Operating Margin (TTM)	4.0%	0.0%
EBITDA Margin (TTM)	16.1%	-31.8%
Net Margin (TTM)	-0.1%	-32.5%
FCF Margin (TTM)	-0.9%	-25.2%
Net Income (TTM)	$-2M	$-110M
FCF (TTM)	$-14M	$-85M
EPS (TTM)	$0.00	-$1.92
ROE (TTM)	-70.0%	-3062.0%
ROA (TTM)	-20.0%	-2211.0%
ROIC (TTM)	-25.0%	-2676.0%
Financial Health
Cash	$0	$228M
Debt	$0	$52M
Net Cash/Debt	$0	$176M
Current Ratio (TTM)	3.60x	6.55x
Quick Ratio (TTM)	1.80x	5.23x
Debt/Equity (TTM)	1.79x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.27	0.88
52W Performance	-9.3%	-47.1%
YTD Performance	11.9%	-40.2%
% from 52W High	-34.4%	-51.7%
% from 52W Low	54.5%	10.4%
Efficiency & Yields
Asset Turnover (TTM)	0.46x	0.68x
FCF Yield (TTM)	-1.4%	-8.1%
Earnings Yield (TTM)	-0.2%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.0	-2.5
EV/GP/RG	0.26	0.12
Ticker research	View IART research	View PRCT research